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New, faster SalmoneUa enteritidis Test 
The current tests used to 
identify Salmonella enteritidis tak:e 
almost two weeks. Dr. Linda 
Keller, research associate professor 
at Penn's Veterinary School, has 
developed an ELISA (enzyme­
linked immunosorbent assay) that 
can determine in just under 30 hours 
whether Salmonella enteritidis is 
present in a sample. "This test is 
based on a very specific monoclonal 
antibody to Salmonella enteritidis,'' 
said Dr. Keller. ''We incubate the 
eggs for 24 hours at 37 C0• Then we 
take a sample of the material and 
"sandwich" it between the 
monoclonal antibodies. We can get 
a reading of the sample i n  about 
three hours.'' 
Because of the large number of 
eggs being cultured at the 
Cooperative Poultry Diagnostic 
Laboratory at New Bolton Center. 
Dr. Keller has been able to com pare 
the results of the ELISA test to 
those from the conventional test and 
verify the accuracy of the new test. 
"It's been very exciting and may be 
a commercial kit can be developed. 
When a reading is negative in a 
suspect house, eggs can be diverted 
back faster to the grade market. 
This helps the farmer. And on the 
other side, if the results are positive, 
control measures can be instituted 
much quicker." 
Herpes l'i �� s a Vector to Deliver Healthy Gene to Br:un 
Herpes virus, after an acute short 
infection, becomes latent in the nerve 
cells. This latency factor plays a key 
role in research by Dr. John Wolfe, 
assistant professor of pathology and 
medical genetics at the School, and Dr. 
Nigel Fraser of the Wistar Institute. 
Dr. Wolfe, a specialist in gene therapy, 
and Dr. Fraser, an expert on herpes 
virus, h:J.Ve collaborated to construct a 
herpes virus vector to deliver a healthy 
gene to central nervous system cells of 
mice afflicted with mucopolysacchari­
dosis (MPS) Vli (Sly disease). 
''The herpes virus is uniquely able 
to transfer genetic material to a brain 
cell without killing it because it is a 
latent virus," notes Dr. Fraser. "The 
advantage of the herpes virus is that it 
can transfer the gene directly to the 
target organ. without removing cells 
from the body and then reimplanting 
them," says Dr. Wolfe. "The healthy 
gene remains active in the brain cells, 
which is important for achieving per­
manent correction of the deficiency." 
The researchers modified a herpes 
simplex virus (HSV-J) and inserted a 
normal gene for enzyme production 
near the location of the virus' latency 
gene to take advantage of that gene's 
ability to activate the normal gene. The 
reconstructed virus was injected into a 
group of mice with MPS VIJ and it was 
found that a small number of central 
nervous system cells then produced the 
proper enzyme over a prolonged period 
of time. 
This is the first time that a genetic 
deficiency in diseased cells of the brain 
has been corrected by gene therapy. 
Drs. Wolfe and Fraser caution that 
further development is needed to cor­
rect enough cells to improve the disease 
in patients. It has been shown, in 
previous studies, that vector­
transferred enzyme activity in MPS Vlf 
can result in correction of the metabol­
ic defect. Thus the expression of 
vector-transferred gene in the central 
nervous system should correct the met­
abolic deficiency. 
Sly disease, an inherited lysosomal 
storage disease, causes mental retarda­
tion and affects the liver, skeletal 
system, heart, eye and brain. lt is a 
rare, but devestating fatal disease of 
humans, and has been identified in 
dogs and mice. lt is estimated that I in 
25,000 human births will result in some 
form of MPS. The disease is caused by 
a genetic deficiency where cells are 
unable to produce an enzyme needed to 
break down complex sugar molecules. 
A mouse afflicttd with MPS VII. 
The molecules accumulate in the cells, 
interfering with normal function. 
Dr. Wolfe points out, that at this 
time, the number of cells showing 
activity of the corrected gene is small. 
However, as knowledge increases, the 
herpes virus vector could become an 
important vehicle to deliver corrective 
genes to the brain and other parts of 
the central nervous system. 
The medical genetics group at the 
School has a long history of investjgat­
ing the genetics, biochemistry, patho­
logy, and treatments of animals with 
genetic diseases. Studies of these natur­
ally-occurring counterparts of human 
genetic diseases have contributed to 
understanding both human and animal 
health. The Wistar Institute is an inde­
pendent basic science research center 
located on the Penn campus with 
programs in virology, molecular gene­
tics, cell and developmental biology, 
cancer therapies, structural biology 
and immunology. 
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